Bryostatin-1: A Novel PKC Inhibitor in Clinical Development
Kortmansky J, Schwartz GK. Bryostatin-1: A Novel PKC Inhibitor in Clinical Development. Cancer Investigation 2003, 21: 924-936. PMID: 14735696, DOI: 10.1081/cnv-120025095.Peer-Reviewed Original ResearchMeSH KeywordsAntineoplastic AgentsApoptosisBryostatinsCell DifferentiationClinical Trials, Phase I as TopicClinical Trials, Phase II as TopicDown-RegulationHumansLactonesMacrolidesNauseaPainProtein Kinase CVomiting